SHANGHAI JUNSHI BIOSCIENCES revenue breakdown overview

SHANGHAI JUNSHI BIOSCIENCES revenue for the last year amounted to 1.50 B CNY, the most of which — 1.50 B CNY — came from its highest performing source at the moment, Innovative Drugs, the year earlier bringing 1.45 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought SHANGHAI JUNSHI BIOSCIENCES 1.16 B CNY, and the year before that — 752.76 M CNY.